2. van Os J, Kapur S. Schizophrenia. Lancet 2009;374:635-645.
3. Keepers GA, Fochtmann LJ, Anzia JM, et al. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry 2020;177:868-872.
4. Barbui C, Purgato M, Abdulmalik J, et al. Efficacy of psychosocial interventions for mental health outcomes in lowincome and middle-income countries: an umbrella review. Lancet Psychiatry 2020;7:162-172.
5. Kim SW. Psychosocial intervention for patients with schizophrenia. J Korean Neuropsychiatr Assoc 2018;57:235-243.
6. Taylor M, Perera U. NICE CG178 psychosis and schizophrenia in adults: treatment and management. An evidencebased guideline? Br J Psychiatry 2015;206:357-359.
7. Jones C, Hacker D, Xia J, et al. Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia. Cochrane Database Syst Rev 2018;12:CD007964.
8. Lecomte T, Leclerc C, Wykes T. Group CBT for psychosis: a guidebook for clinicians. Oxford University Press; 2016.
10. Moritz S, Veckenstedt R, Andreou C, et al. Sustained and “sleeper” effects of group metacognitive training for schizophrenia: a randomized clinical trial. JAMA Psychiatry 2014;71:1103-1111.
13. Pharoah F, Mari J, Rathbone J, Wong J. Family intervention for schizophrenia. Cochrane Database Syst Rev 2010:CD000088.
14. Grácio J, Gonçalves-Pereira M, Leff J. Key elements of a family intervention for schizophrenia: a qualitative analysis of an RCT. Fam Process 2018;57:100-112.
15. Nuechterlein KH, Subotnik KL, Turner LR, Ventura J, Becker DR, Drake RE. Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment. Psychiatr Rehabil J 2008;31:340-349.
16. Dixon LB, Dickerson F, Bellack AS, et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 2010;36:48-70.
18. Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry 2017;4:295-301.
20. Korman N, Stanton R, Vecchio A, et al. The effect of exercise on global, social, daily living and occupational functioning in people living with schizophrenia: a systematic review and meta-analysis. Schizophr Res 2023;256:98-111.
22. Kim EJ, Lim SY, Lee HJ, et al. Low dietary intake of n-3 fatty acids, niacin, folate, and vitamin C in Korean patients with schizophrenia and the development of dietary guidelines for schizophrenia. Nutr Res 2017;45:10-18.
28. Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev 2000;(2):CD001089.
30. Lee GY, Yu HY, Jhon M, Yoon JS, Kim SW. Intensive cognitive behavioral case management for functional recovery of young patients with schizophrenia. Korean J Schizophr Res 2016;19:32-37.
34. Kane JM, Robinson DG, Schooler NR, et al. Response to AMOS: addressing purported methodological flaws in RAISE-ETP results. Am J Psychiatry 2016;173:535-536.
35. McGorry PD. The recognition and optimal management of early psychosis: an evidence-based reform. World Psychiatry 2002;1:76-83.
36. Kim SW, Kim JK, Park C, et al. Early intervention model for mental health in Korean youth: Mindlink. Korean J Schizophr Res 2022;25:1-9.
41. Ranjan T, Melcher J, Keshavan M, Smith M, Torous J. Longitudinal symptom changes and association with home time in people with schizophrenia: an observational digital phenotyping study. Schizophr Res 2022;243:64-69.
44. Lee HJ, Cho CH, Lee T, et al. Prediction of impending mood episode recurrence using real-time digital phenotypes in major depression and bipolar disorders in South Korea: a prospective nationwide cohort study. Psychol Med 2023;53:5636-5644.
50. Freeman D, Lister R, Waite F, et al. Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analyses. Lancet Psychiatry 2023;10:836-847.
51. Haley C, O’Callaghan E, Hill S, et al. Telepsychiatry and carer education for schizophrenia. Eur Psychiatry 2011;26:302-304.
52. Kim SW. Supporting patients with schizophrenia in the era of COVID-19. Korean J Schizophr Res 2021;24:45-51.
54. Plowman RS, Peters-Strickland T, Savage GM. Digital medicines: clinical review on the safety of tablets with sensors. Expert Opin Drug Saf 2018;17:849-852.
55. Goold I. Digital tracking medication: big promise or Big Brother? Law Innov Technol 2019;11:203-230.
57. Annajigowda HH, Chaturvedi SK. Digital mental health: a way forward for public mental health. World Soc Psychiatry 2023;5:153-157.
59. Kim SW, Lee GY, Yu HY, et al. Development of smartphone application for cognitive behavioral therapy-based case management in patients with schizophrenia. Korean J Schizophr Res 2016;19:10-16.